Home  >  Products  >  Mapk12 (mitogen-activated protein kinase 12) Blocking Peptide (the C terminal of Mapk12)(100ug)
Mapk12 (mitogen-activated protein kinase 12) Blocking Peptide (the C terminal of Mapk12)(100ug)

Mapk12 (mitogen-activated protein kinase 12) Blocking Peptide (the C terminal of Mapk12)(100ug)


Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-Mapk12 Antibody (ARP56536_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Mouse
Presku: AAP56536
Size: 100ug
Weight: 40kDa
Gene: 29857
Format: Lyophilized powder
Target: Mapk12 responds to activation by environmental stress and pro-inflammatory cytokines by phosphorylating downstream targets. Mapk12 plays a role in myoblast differentiation and also in the down-regulation of cyclin D1 in response to hypoxia in adrenal cells suggesting MAPK12 may inhibit cell proliferation while promoting differentiation.
Alternative names: AW123708; Erk6; P38gamma; Prkm12; Sapk3